SCHEMBL27711111

SCHEMBL27711111

CN1CCC(C(=O)NCc2cc(-c3ccc4[nH]ccc4c3)ccc2F)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.45
▸ MTOR P42345 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ GSK3B P49841 2/20 0.44
▸ GSK3A P49840 1/20 0.44
▸ FASN P49327 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ROCK2 O75116 1/20 0.43
▸ EPHX2 P34913 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.41
▸ DYRK1A Q13627 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ PKM P14618 1/20 0.40
▸ LTA4H P09960 1/20 0.40
▸ CREBBP Q92793 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27731712 0.83 WDR5 (0.47) ABL1MTORGSK3BGSK3AMAPT
SCHEMBL3700050 0.83 MTOR (0.41) ABL1MTORKDM4EFASNROCK2
SCHEMBL3707626 0.81 FASN (0.38) ABL1MTORGSK3BGSK3AFASN
SCHEMBL24424559 0.81 KDM4E (0.52) KDM4EMAPTROCK2LMNAALDH1A1
SCHEMBL3699072 0.76 BRD4 (0.40) FASNROCK2EPHX2TRPV1CREBBP
SCHEMBL3701259 0.75 FASN (0.42) FASN
SCHEMBL24423574 0.74 DYRK1A (0.44) ABL1KDM4EGSK3BMAPTROCK2
SCHEMBL3700861 0.74 FASN (0.42) FASN
SCHEMBL6730692 0.74 FASN (0.42) ABL1KDM4EFASNDYRK1A
SCHEMBL3692104 0.73 TP53 (0.45) FASNDYRK1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101242819-A Hypnotics and combinations of substituted biaryl and heteroaryl compounds and therapeutic uses thereof AVENTIS PHARMA INC (US) 2008-08-13 — — CN disclosed
Send feedback